Survival and Hemodynamic Effects of Parenteral Prostanoids in High‐Altitude Group 1 Pulmonary Hypertension: A Retrospective Cohort Study

Documenti analoghi

• Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
  di: Brandon Budhram, et al.
  Pubblicazione: (2025)
• The Discovery of Inhaled Prostanoids for Pulmonary Hypertension
  di: Werner Seeger
  Pubblicazione: (2025)
• The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3
  di: Katherine Bunclark, et al.
  Pubblicazione: (2026)
• Why Wait for Sick People to Get Sicker? The Paradox of the Treatment of Patients With Pulmonary Arterial Hypertension
  di: Mauricio Orozco‐Levi, et al.
  Pubblicazione: (2025)
• Role of a New Walk Test in Pulmonary Arterial Hypertension: A Retrospective Cohort Study
  di: Junhao Jin, et al.
  Pubblicazione: (2025)